Akira Terabe

679 total citations
8 papers, 550 citations indexed

About

Akira Terabe is a scholar working on Pharmaceutical Science, Gastroenterology and Genetics. According to data from OpenAlex, Akira Terabe has authored 8 papers receiving a total of 550 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pharmaceutical Science, 4 papers in Gastroenterology and 4 papers in Genetics. Recurrent topics in Akira Terabe's work include Advanced Drug Delivery Systems (5 papers), Gastrointestinal motility and disorders (4 papers) and Inflammatory Bowel Disease (4 papers). Akira Terabe is often cited by papers focused on Advanced Drug Delivery Systems (5 papers), Gastrointestinal motility and disorders (4 papers) and Inflammatory Bowel Disease (4 papers). Akira Terabe collaborates with scholars based in Japan and United States. Akira Terabe's co-authors include Hideyuki Tozaki, Shozo Muranishi, Akira Yamamoto, Tsutomu Suzuki, Junta Komoike, Chika Tada, Takako Maruyama, Takuya Fujita, Susumu Okabe and Naoki Okada and has published in prestigious journals such as Journal of Controlled Release, Industrial & Engineering Chemistry Research and Life Sciences.

In The Last Decade

Akira Terabe

8 papers receiving 513 citations

Peers

Akira Terabe

PS

BIOMA

GASTR

MB

FS

Hideyuki Tozaki Japan

Junta Komoike Japan

C.M. Savariar Malaysia

Irit Gliko-Kabir Israel

Dianzhou Bi China

Arati Deshpande United States

Naijing Ye China

Meisi Lin China

Y. Indira Muzib India

Yohko Akiyama Japan

Hideyuki Tozaki Japan

Akira Terabe

490 ×1.4

PS

118 ×0.8

BIOMA

111 ×1.4

GASTR

145 ×2.0

MB

99 ×1.4

FS

Citations per year, relative to Akira Terabe Akira Terabe (= 1×) peers Hideyuki Tozaki

Countries citing papers authored by Akira Terabe

Since Specialization

Citations

This map shows the geographic impact of Akira Terabe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akira Terabe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akira Terabe more than expected).

Fields of papers citing papers by Akira Terabe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Akira Terabe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akira Terabe. The network helps show where Akira Terabe may publish in the future.

Co-authorship network of co-authors of Akira Terabe

This figure shows the co-authorship network connecting the top 25 collaborators of Akira Terabe. A scholar is included among the top collaborators of Akira Terabe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Akira Terabe. Akira Terabe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Tozaki, Hideyuki, Naoki Okada, Takuya Fujita, et al.. (2002). Chitosan capsules for colon-specific drug delivery: enhanced localization of 5-aminosalicylic acid in the large intestine accelerates healing of TNBS-induced colitis in rats. Journal of Controlled Release. 82(1). 51–61. 154 indexed citations

2.

Tozaki, Hideyuki, Takuya Fujita, Akira Terabe, et al.. (1999). Colon-specific delivery of R68070, a new thromboxane synthase inhibitor, using chitosan capsules: Therapeutic effects against 2,4,6-trinitrobenzene sulfonic acid-induced ulcerative colitis in rats. Life Sciences. 64(13). 1155–1162. 45 indexed citations

3.

Tozaki, Hideyuki, Takuya Fujita, Akira Terabe, et al.. (1999). Validation of a Pharmacokinetic Model of Colon-specific Drug Delivery and the Therapeutic Effects of Chitosan Capsules Containing 5-Aminosalicylic Acid on 2,4,6-Trinitrobenzenesulphonic Acid-induced Colitis in Rats. Journal of Pharmacy and Pharmacology. 51(10). 1107–1112. 38 indexed citations

4.

Tozaki, Hideyuki, Takuya Fujita, Masahiro Murakami, et al.. (1998). Colon delivery of anti-inflammatory drugs accelerates healing of TNBS induced-colitis in rats.. Drug Delivery System. 13(3). 165–171. 5 indexed citations

5.

Tozaki, Hideyuki, Junta Komoike, Chika Tada, et al.. (1997). Chitosan Capsules for Colon-Specific Drug Delivery: Improvement of Insulin Absorption from the Rat Colon. Journal of Pharmaceutical Sciences. 86(9). 1016–1021. 254 indexed citations

6.

Tozaki, Hideyuki, Takuya Fujita, Akira Yamamoto, et al.. (1996). Chitosan capsules for colon-specific drug delivery: Improvement of insulin absorption from the rat colon.. Drug Delivery System. 11(2). 119–124. 8 indexed citations

7.

Yamamoto, Akira, Takuya Fujita, Shozo Muranishi, et al.. (1995). CHITOSAN CAPSULES FOR COLON-SPECIFIC DRUG DELIVERY: IMPROVEMENT OF INSULIN ABSORPTION FROM THE RAT COLON. Drug Metabolism and Pharmacokinetics. 10(supplement). 88–91. 1 indexed citations

8.

Yoshihara, Kazutoshi, et al.. (1991). Reaction between chitosan and cellulose on biodegradable composite film formation. Industrial & Engineering Chemistry Research. 30(4). 788–792. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact